CN Stock MarketDetailed Quotes

605199 Hainan Huluwa Pharmaceutical Group

Watchlist
  • 9.31
  • -0.15-1.59%
Trading Jul 24 11:08 CST
3.73BMarket Cap39.28P/E (TTM)

Hainan Huluwa Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Product Currency:CNY
2023/FY
Stock NameRevenueRatio
Respiratory drug1.14B59.86%
Digestive system drugs400.14M21.00%
Other drugs218.05M11.45%
全身用抗感染药物146.63M7.70%
Industry Currency:CNY
2023/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing industry1.91B100.00%
Region Currency:CNY
2023/FY
Stock NameRevenueRatio
East China425.35M22.33%
Central China421.15M22.11%
Southwest369.03M19.37%
South China277.17M14.55%
North China266.2M13.97%
Northwest88.07M4.62%
Northeast China58.21M3.06%
Other----
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg